A Study of the Alternative Administration of Ixabepilone and Vinflunine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Cancer

Interventions

DRUG

vinflunine + ixabepilone

solution for injection, IV, vinflunine: 250 to 320 mg/m2 + ixabepilone: 30 to 40 mg/m2, every 3 wks, variable duration

Trial Locations (2)

University Of Miami Miller School Of Medicine, Miami

The Cleveland Clinic Foundation, Cleveland